Latest filing published 08 Jun 2022 for Repare Therapeutics Inc., €2.3M.
Filing timeline
BuySaleInsider track record
Versant Venture Capital VI, L.P.: trading record in brief
Versant Venture Capital VI, L.P. is a declared insider of Repare Therapeutics Inc., with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 22 June 2020 and the latest from 3 June 2022.
Sales make up the whole of the open-market record (1 sale, €2.3M). Since January 2022: no purchases and 1 sale on the market.
Most recently, on 8 June 2022, the filings show an open-market sale worth €2.3M in Repare Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 9 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Versant Venture Capital VI, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 shares@ CA$12.251763.4% of flowCommon SharesTSXSEDI:3958431
- 300,000 sharesCommon SharesTSXSEDI:3681032
- 250,000 sharesCommon SharesTSXSEDI:3671827
- 275,000 sharesCommon SharesTSXSEDI:3663705
- 100,000 shares@ CA$20.0036.6% of flowCommon SharesTSXSEDI:3570618
- 2,443,883 sharesCommon SharesTSXSEDI:3570615
- Convertible Preferred Shares class B convertible preferred sharesTSXSEDI:3570612
- Convertible Preferred Shares class A convertible preferred sharesTSXSEDI:3570611
- 875,568 sharesConvertible Preferred Shares class B convertible preferred sharesTSXSEDI:3570616
- Common SharesTSXSEDI:3570614
- 2,443,883 sharesConvertible Preferred Shares class A convertible preferred sharesTSXSEDI:3570613
- 875,568 sharesCommon SharesTSXSEDI:3570617
12 of 12 declarations
